SCYNEXIS Future Growth
Future criteria checks 0/6
SCYNEXIS's revenue is forecast to decline at 4.8% per annum while its annual earnings are expected to grow at 0.04% per year. EPS is expected to decline by 3.4% per annum.
Key information
0.04%
Earnings growth rate
-3.4%
EPS growth rate
Pharmaceuticals earnings growth | 20.6% |
Revenue growth rate | -4.8% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 10 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 114 | 73 | 13 | 20 | 5 |
12/31/2025 | 41 | -1 | -28 | -21 | 5 |
12/31/2024 | 31 | -10 | N/A | -26 | 5 |
12/31/2023 | 140 | 67 | 60 | 60 | N/A |
9/30/2023 | 136 | 72 | 45 | 45 | N/A |
6/30/2023 | 136 | 44 | 10 | 10 | N/A |
3/31/2023 | 6 | -91 | -83 | -83 | N/A |
12/31/2022 | 5 | -63 | -80 | -80 | N/A |
9/30/2022 | 4 | -78 | -83 | -83 | N/A |
6/30/2022 | 3 | -49 | -78 | -77 | N/A |
3/31/2022 | 2 | -34 | -71 | -70 | N/A |
12/31/2021 | 13 | -33 | -56 | -55 | N/A |
9/30/2021 | 13 | -46 | -46 | -46 | N/A |
6/30/2021 | 12 | -45 | -39 | -39 | N/A |
3/31/2021 | 12 | -53 | -36 | -36 | N/A |
12/31/2020 | N/A | -55 | -49 | -49 | N/A |
9/30/2020 | N/A | -27 | -46 | -46 | N/A |
6/30/2020 | N/A | -36 | -47 | -47 | N/A |
3/31/2020 | 0 | -38 | -46 | -46 | N/A |
12/31/2019 | 0 | -54 | -38 | -38 | N/A |
9/30/2019 | 0 | -37 | -31 | -31 | N/A |
6/30/2019 | 0 | -29 | -27 | -26 | N/A |
3/31/2019 | 0 | -31 | -27 | -27 | N/A |
12/31/2018 | 0 | -12 | -29 | -28 | N/A |
9/30/2018 | 0 | -22 | -28 | -27 | N/A |
6/30/2018 | 0 | -31 | -27 | -27 | N/A |
3/31/2018 | 0 | -24 | -26 | -26 | N/A |
12/31/2017 | 0 | -25 | -25 | -25 | N/A |
9/30/2017 | 0 | -21 | N/A | -24 | N/A |
6/30/2017 | 0 | -24 | N/A | -26 | N/A |
3/31/2017 | 0 | -28 | N/A | -27 | N/A |
12/31/2016 | 0 | -30 | N/A | -29 | N/A |
9/30/2016 | 0 | -35 | N/A | -31 | N/A |
6/30/2016 | 0 | -31 | N/A | -30 | N/A |
3/31/2016 | 0 | -30 | N/A | -29 | N/A |
12/31/2015 | 0 | -28 | N/A | -25 | N/A |
9/30/2015 | 1 | -23 | N/A | -20 | N/A |
6/30/2015 | 1 | -19 | N/A | -18 | N/A |
3/31/2015 | 1 | -11 | N/A | -14 | N/A |
12/31/2014 | 1 | -7 | N/A | -9 | N/A |
9/30/2014 | 4 | -42 | N/A | -9 | N/A |
6/30/2014 | 8 | -43 | N/A | -6 | N/A |
3/31/2014 | 12 | -47 | N/A | -2 | N/A |
12/31/2013 | 17 | -47 | N/A | -4 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 135A's forecast earnings growth (0.04% per year) is below the savings rate (0.6%).
Earnings vs Market: 135A's earnings (0.04% per year) are forecast to grow slower than the German market (15.1% per year).
High Growth Earnings: 135A's earnings are forecast to grow, but not significantly.
Revenue vs Market: 135A's revenue is expected to decline over the next 3 years (-4.8% per year).
High Growth Revenue: 135A's revenue is forecast to decline over the next 3 years (-4.8% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 135A's Return on Equity is forecast to be high in 3 years time